about
Expansion of the Multi-Link Frontier™ coronary bifurcation stent: micro-computed tomographic assessment in human autopsy and porcine heart samplesHyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesComparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.Effect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease: a post hoc analysis of data from a prospective, randomized, double-blind study.Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytesIncidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiographyDiagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment.Alterations of leptin in the course of inflammation and severe sepsis.Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I.Design and Rationale of the Femoral Closure versus Radial Compression Devices Related to Percutaneous Coronary Interventions (FERARI) Study.Arterial access-site complications after use of a vascular closure device related to puncture height.Prevalence, Clinical Characteristics, and Predictors of Patients with Thromboembolic Events in Takotsubo Cardiomyopathy.Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions.Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction.Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes.Endothelial cell-specific molecule-1/endocan: Diagnostic and prognostic value in patients suffering from severe sepsis and septic shock.Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients.High Sensitivity Troponins Discriminate Different Morphologies of Coronary Artery Plaques Being Assessed by Coronary Computed Tomography Angiography.Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANPComparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.High sensitivity troponin T and I reflect mitral annular plane systolic excursion being assessed by cardiac magnetic resonance imaging.Enhanced proinflammatory response of mononuclear cells to in vitro LPS-challenge in patients with ventricular fibrillation in the setting of acute myocardial infarction.Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors.Intercellular adhesion molecule 1 (ICAM-1)--a new substrate for the development of ventricular fibrillation?Prognostic value of platelet-derived growth factor in patients with severe sepsis.Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure.Elevation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in patients presenting with acute myocardial infarction.Time-course of neopterin levels in patients suffering from severe sepsis treated with and without Drotrecogin-alpha (activated).Age related differences and outcome of patients with Takotsubo syndrome.Impact and management of left ventricular function on the prognosis of Takotsubo syndrome.Revisiting the prognostic value of monocyte chemotactic protein 1 and interleukin-6 in the sepsis-3 era.Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.High sensitivity troponin T and I reflect left atrial function being assessed by cardiac magnetic resonance imaging.Tackling myocardial metabolism: one year evaluation of free fatty acids, norephinephrine and NT-proBNP in ventricular fibrillation during STEMI.Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes.Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy.Connective tissue growth factor (CTGF/CCN2): diagnostic and prognostic value in acute heart failure.Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
P50
Q28479223-7319CD9A-38CF-49BA-8FE7-3F7A25DADC02Q28553287-CA52BB82-FFF5-496E-926D-4757ABB17200Q33159224-9E8515C8-A22A-4608-833A-E2C3B5023FA0Q33571435-03FB32EC-DB00-4FDA-B059-F1931BF37FB4Q33774097-88DE4DCC-C566-402E-8174-FEA7BE03F3C4Q34034720-E2E13DF0-C4A5-40E6-9605-99F86527C0B7Q34240021-BC29A27B-B364-4C1D-8CB4-47C10CE77459Q34413809-F8AF4799-1EBA-49A0-AB79-B0BC20474BE8Q34723139-DDCA0F09-8716-49DD-B017-81434FC4AAA8Q35662925-B75D85ED-8C2D-46A9-809B-F511540C4957Q36256691-6501A4AB-A597-48C2-9C1B-25FBEA454CD2Q36283455-53924199-25D8-4522-925C-2DBF07A154C9Q37094809-C949B0C2-9DA5-44CE-B799-438979733EF5Q40030731-ECD432D0-BD85-4D65-BB46-6316D3226EE0Q40099975-23A9CEBC-C833-45BF-AC19-6F5AB6702730Q40144795-4E880FB9-DF42-41D7-8F37-7EB5A4A9E092Q40557502-A9B7B5F9-77DD-4322-B358-D59D490493CEQ40942121-D5BA3FFA-63B6-4B56-96CD-F92732A86CA1Q41147879-F6CE43EB-DEBF-4C72-A610-64C5850742E6Q41215009-CE24611A-D896-4A9E-85DD-33494B551DFAQ41490689-B17CB4ED-CE83-480B-B30A-5C9FD8A5E224Q41702376-961B0E4D-7757-4011-9EE8-339C2159E3F9Q42117264-19D67A5B-2FBC-4D24-BC83-55662026A61CQ42437745-7E7E2C9F-1776-450B-8F0E-25782A158A50Q43419536-80150B5A-1E40-423B-94D4-14415A67A618Q43501722-A5C2F01B-EF82-4FD5-9F3B-BD1692F99773Q43782027-B67AD176-9A93-4B4B-AA76-2E9130223EA5Q43807471-C426CE09-24FD-4E7F-A305-E9C71BE81443Q46092121-994C3053-39AE-469B-B5A5-D13299E786F2Q46515389-3B1ECA37-27FA-4CAC-9AB8-F5362B648006Q47158184-C444779C-FA21-4CE5-BA5E-EBAEA29371B6Q47888067-BFFA274F-E8F1-45E9-9F47-6F3BCCA4B97AQ47914738-54768094-9ADC-4203-9CDA-9E238D691F0CQ48087191-AA5D7BE4-FD3F-49A1-BFED-901ADB2ACDA6Q48221322-5C5282E6-C855-43F0-BA08-967266F9F1BBQ48729152-452274EC-D7F5-4BBC-82C0-90E4EC9A04D4Q48741700-F5B7D803-8B1B-4843-B25B-D559D6F596B7Q48744881-89A630D8-B402-471A-87C2-93E7EA2B1A42Q48920776-B8A216CE-6D9A-4DD3-A024-3A4D4E3DBFB0Q49117498-1C9D980A-84E8-47A6-99E8-C213445097DF
P50
name
Siegfried Lang
@en
type
label
Siegfried Lang
@en
prefLabel
Siegfried Lang
@en